NCT06783218View on ClinicalTrials.gov

An Integrative Study of the Role of Microbiome, Metabolome, Transcriptome and Chronobiology in the Context of Type 2 Diabetes.

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

March 21, 2024

Primary Completion Date

October 15, 2024

Study Completion Date

October 28, 2024

Conditions
Prediabetes / Type 2 DiabetesObesity and OverweightInsulin Resistance
Trial Locations (1)

31008

Center for Nutrition Research. University of Navarra, Pamplona

All Listed Sponsors
collaborator

European Union Next Generation

UNKNOWN

collaborator

Ministry of Science and Innovation, Spain

OTHER_GOV

collaborator

Government of Navarra

UNKNOWN

collaborator

CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn).

UNKNOWN

lead

Clinica Universidad de Navarra, Universidad de Navarra

OTHER

NCT06783218 - An Integrative Study of the Role of Microbiome, Metabolome, Transcriptome and Chronobiology in the Context of Type 2 Diabetes. | Biotech Hunter | Biotech Hunter